祝贺聂鹏研究员有关全球糖尿病变化的合作研究被Nature Medicine接收
点击次数：
发布时间：2023-08-15
发布时间：2023-08-15
文章标题：祝贺聂鹏研究员有关全球糖尿病变化的合作研究被Nature Medicine接收
内容：
8月14日，聂鹏研究员作为NCD-RisC团队成员有关“Global variations in diabetes mellitus based on fasting glucose and haemoglobin A1c”的合作研究被Nature Medicine接收。
Summary
Fasting plasma glucose (FPG) and haemoglobin A1c (HbA1c) are both used to diagnose diabetes, but may identify different people as having diabetes. We used data from 117 population-based studies and quantified, in different world regions, the prevalence of diagnosed diabetes, and whether those who were previously undiagnosed and detected as having diabetes in survey screening had elevated FPG, HbA1c, or both. We developed prediction equations for estimating the probability that a person without previously diagnosed diabetes, and at a specific level of FPG, had elevated HbA1c, and vice versa. The age-standardised proportion of diabetes that was previously undiagnosed, and detected in survey screening, ranged from 30% in the high-income western region to 66% in south Asia. Among those with screen-detected diabetes with either test, the age-standardised proportion who had elevated levels of both FPG and HbA1c was 29-39% across regions; the remainder had discordant elevation of FPG or HbA1c. In most low- and middle-income regions, isolated elevated HbA1c more common than isolated elevated FPG. In these regions, the use of FPG alone may delay diabetes diagnosis and underestimate diabetes prevalence. Our prediction equations help allocate finite resources for measuring HbA1c to reduce the global gap in diabetes diagnosis and surveillance.